“Sirt6BAC” mice overexpress SIRT6 in a physiological manner unattained previously.
SIRT6 overexpression protects against aberrant glucose homeostasis.
Sirt6BAC mice exhibit enhanced insulin sensitivity in skeletal muscle and liver.
Pharmacologically enhancing SIRT6 activity may be a viable way to treat diabetes.